(S)-1-(5-FLUOROPYRIDIN-3-YL)ETHANAMINE HCL, 95.0%, 250mg

3-Bromo-4-chloro-5-fluoropyridine, 95.0%, 250mg

2-Methylnaphtho[2,1-d]oxazole, 95.0%, 10g

tert-Butyl 4-(isopropylamino)piperidine-1-carboxylate, 95.0%, 1g

4-Nitrobenzene-1,3-diol, 95.0%, 100mg

(Bromodifluoromethyl)trimethylsilane, 98%, 25g

1-(3-Bromopropoxy)-2-fluorobenzene, 97%, 250mg

2,2,2-TRIFLUORO-1-(3-FLUOROPHENYL)ETHANOL, 95.0%, 1g

4,4,5,5-Tetramethyl-2-(4-phenylnaphthalen-1-yl)-1,3,2-dioxaborolane, 97%, 1g

Incubator BD series with natural air movement (convection), 20 l, BD 23, 1 piece

(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(pyridin-4-yl)butanoic acid, 95+%, 500mg

Methyl 5-((tert-butoxycarbonyl)amino)thiazole-2-carboxylate, 98%, 100mg

Rivastigmine, 95.0%, 100mg